T1	Participants 301 364	visual function in symptomatic VMA/vitreomacular traction (VMT)
T2	Participants 624 653	patients with symptomatic VMA
T3	Participants 929 1032	652 patients with symptomatic VMA/VMT, including when associated with a macular hole 400 Î¼m or smaller,
T4	Participants 1131 1164	Patients with symptomatic VMA/VMT
T5	Participants 1690 1702	464 patients